Table 4 Maximum residues limits (MRL*), CCβ and number of samples analyzed for each antibiotic used for the validation of the selected method
Family of antibiotics | Antibiotics | MRL in milk (μg/L) | CCβ (μg/L) | Detection | |
|---|---|---|---|---|---|
CCβ spiked | CCβ Blank samples | ||||
Penicillins | Amoxicillin | 4 | 2 | 20/20 | 20/20 |
Penicillin G | 4 | 2 | 20/20 | 20/20 | |
Ampicillin | 4 | 2 | 20/20 | 19/20 | |
Cloxacillin | 30 | 15 | 20/20 | 20/20 | |
Dicloxacillin | 30 | 15 | 20/20 | 19/20 | |
Nafcillin | 30 | 15 | 20/20 | 20/20 | |
Oxacillin | 30 | 15 | 20/20 | 20/20 | |
Quinolones | Enrofloxacin | 100 | 50 | 20/20 | 20/20 |
Marbofloxacin | 75 | 37.5 | 20/20 | 20/20 | |
Flumequine | 50 | 25 | 20/20 | 19/20 | |
Macrolides | Erythromycin | 40 | 20 | 20/20 | 19/20 |
Spiramycin | 200 | 100 | 20/20 | 20/20 | |
Tilmicosin | 50 | 25 | 20/20 | 20/20 | |
Tylosin | 50 | 25 | 20/20 | 19/20 | |
Neospiramycin | 200 | 100 | 20/20 | 20/20 | |
Tetracyclines | Chlortetracycline | 100 | 50 | 20/20 | 20/20 |
Oxytetracycline+ 4-epi-oxytetracycline | 100 | 50 | 20/20 | 20/20 | |
Tetracycline+ 4-epi-Tetracycline | 100 | 50 | 20/20 | 20/20 | |
Sulfonamides | Sulfadiazine | 100 | 50 | 20/20 | 20/20 |
Sulfapyridine | 100 | 50 | 20/20 | 20/20 | |
| Â | Sulfamethoxypyridazine | 100 | 50 | 20/20 | 20/20 |
Sulfadoxine | 100 | 50 | 20/20 | 20/20 | |
Sulfadimethoxine | 100 | 50 | 20/20 | 20/20 | |
Sulfadimidine | 100 | 50 | 20/20 | 20/20 | |
Sulfamonomethoxine | 100 | 50 | 20/20 | 20/20 | |
Sulfamoxole | 100 | 50 | 20/20 | 20/20 | |
Sulfaquinoxaline | 100 | 50 | 20/20 | 20/20 | |
Sulfachloropyridazine | 100 | 50 | 20/20 | 20/20 | |
Sulfathiazole | 100 | 50 | 20/20 | 20/20 | |
Sulfamerazine | 100 | 50 | 20/20 | 20/20 | |
Sulfamethoxazole | 100 | 50 | 20/20 | 20/20 | |
Sulfacetamide | 100 | 50 | 20/20 | 20/20 | |
Sulfisoxazole | 100 | 50 | 20/20 | 19/20 | |
Trimethoprim | 50 | 25 | 20/20 | 20/20 | |
Sulfaguanidine | 100 | 50 | 20/20 | 20/20 | |
Sulfamethizole | 100 | 50 | 20/20 | 20/20 | |